NEW ORLEANS (MedPage Today) — Older patients with a hip fracture are more likely to die when admitted to hospitals with lower nurse staffing levels, a retrospective study showed.
No Comments »
Filed under: General Health News
Metabolic drugs (MedPage Today) — namely cholesterol and diabetes meds — account for the greatest Medicare prescription expenses, researchers say.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — President Barack Obama has announced new measures aimed at cracking down on fraud and waste in government programs, including Medicare and Medicaid.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — Virginia has become the first state in the country to ban any requirement that its residents carry health insurance policies.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The Senate has voted 62-36 to approve a $138 billion bill that would, among other things, stave off planned cuts to Medicare reimbursements until Oct 1.
No Comments »
Filed under: General Health News
Bisphosphonate drugs for osteoporosis do not seem to increase the risk of femoral fractures, the FDA announced Wednesday, though the agency will continue to evaluate that possibility.
No Comments »
Filed under: Pharmacy News
WASHINGTON (MedPage Today) — The FDA has approved a new indication for onabotulinumtoxin A (Botox) as a flexor muscle spasm treatment for the elbow, wrist, and fingers in adult patients.
No Comments »
Filed under: Pharmacy News
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that the U.S. Food and Drug Administration has provided guidance on the clinical program required to assess the approvability of Restanza™ (cethromycin), a novel oral [...]
No Comments »
Filed under: Pharmacy News
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and serious viral infections, today announced financial results for the third quarter of fiscal year (FY) 2010 ended January 31, 2010. The company also provided an update on its clinical programs and corporate developments.
No Comments »
Filed under: Pharmacy News
BioSante Pharmaceuticals, Inc. today announced positive results of a human clinical study that show that its GVAX Leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Gleevec (imatinib mesylate).
No Comments »
Filed under: Pharmacy News
